Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Macrophages play a critical role in breast cancer progression.
• Macrophages are broadly classified as M1 (antitumoral) or M2 (protumoral) based on distinct phenotypes.
• The precise markers and conditions defining protumoral macrophage phenotypes remain unclear.

Purpose of the Study:

• To investigate the markers and conditions associated with M1/M2 and protumoral macrophage polarization in breast cancer.
• To clarify the phenotype of macrophages involved in promoting breast cancer progression.

Main Methods:

• Monocytic cell lines and primary monocytes were subjected to M1/M2 polarization protocols.
• Cells were exposed to conditions known to induce protumoral functions.
• Expression of key M1 and M2 markers, as well as inflammatory mediators, was analyzed.

Main Results:

• Only indoleamine 2,3-dioxygenase (IDO) and CD86 showed consistent upregulation correlating with M1 polarization.
• Markers such as TNF-α, CCR7, IL-10, arginase I, CD36, and CD163 were expressed similarly in both M1 and M2 polarized cells.
• Protumoral conditions led to upregulation of both M1 and M2 markers, with aggressive breast cancer cell line media inducing the most significant changes.
• M1-polarized macrophages exhibited the highest expression/secretion of inflammatory mediators linked to breast cancer aggressiveness.

Conclusions:

• The phenotype of protumoral macrophages is complex and not strictly M1 or M2.
• Conditions driving protumoral macrophage formation likely involve a combination of M1 and M2 stimuli.
• Further research is needed to precisely define protumoral macrophage phenotypes and their formation triggers in breast cancer.